Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer

Nucleic Acids Research

Volumn 42, Issue 6, 2014, Pages 3607-3622

  Wu, Dayong ^a   Sunkel, Benjamin ^a,b   Chen, Zhong ^a   Liu, Xiangtao ^a   Ye, Zhenqing ^c   Li, Qianjin ^a   Grenade, Cassandra ^a   Ke, Jingdong ^a   Zhang, Chunpeng ^a   Chen, Hongyan ^a,d   Nephew, Kenneth P ^c   Huang, Tim H M ^c   Liu, Zhihua ^d   Jin, Victor X ^c,e   Wang, Qianben ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d CANCER HOSPITAL   (China)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE ACETYLTRANSFERASE PCAF; MEDIATOR COMPLEX; PROTEIN MED1; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

AR GENE; ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION;

BINDING SITES; CELL LINE, TUMOR; CHROMATIN; ENHANCER ELEMENTS, GENETIC; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 84899017831     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1382     Document Type: Article

References (66)

1. De Gendt, K. and Verhoeven, G. (2012) Tissue-and cell-specific functions of the androgen receptor revealed through conditional knockout models in mice. Mol. Cell. Endocrinol., 352, 13-25.
2. Lonergan, P. E. and Tindall, D. J. (2011) Androgen receptor signaling in prostate cancer development and progression. J. Carcinog., 10, 20.
3. Heinlein, C. A. and Chang, C. (2004) Androgen receptor in prostate cancer. Endocr. Rev., 25, 276-308.
4. Denmeade, S. R. and Isaacs, J. T. (2002) A history of prostate cancer treatment. Nat. Rev. Cancer, 2, 389-396.
5. Feldman, B. J. and Feldman, D. (2001) The development of androgen-independent prostate cancer. Nat. Rev. Cancer, 1, 34-45.
6. Pienta, K. J. and Bradley, D. (2006) Mechanisms underlying the development of androgen-independent prostate cancer. Clin. Cancer Res., 12, 1665-1671.
7. Knudsen, K. E. and Penning, T. M. (2010) Partners in crime: deregulation of AR activity and androgen synthesis in prostate cancer. Trends Endocrinol. Metabol., 21, 315-324.
8. Jozwik, K. M. and Carroll, J. S. (2012) Pioneer factors in hormonedependent cancers. Nat. Rev. Cancer, 12, 381-385.
9. Augello, M. A., Hickey, T. E. and Knudsen, K. E. (2011) FOXA1: master of steroid receptor function in cancer. EMBO J., 30, 3885-3894.
10. Zaret, K. S. and Carroll, J. S. (2011) Pioneer transcription factors: establishing competence for gene expression. Genes Dev., 25, 2227-2241.
11. Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R. et al. (2005) Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell, 122, 33-43.
12. Wang, Q., Li, W., Liu, X. S., Carroll, J. S., Janne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J. and Brown, M. (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell, 27, 380-392.
13. Jia, L., Berman, B. P., Jariwala, U., Yan, X., Cogan, J. P., Walters, A., Chen, T., Buchanan, G., Frenkel, B. and Coetzee, G. A. (2008) Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. PLoS One, 3, e3645.
14. John, S., Sabo, P. J., Thurman, R. E., Sung, M. H., Biddie, S. C., Johnson, T. A., Hager, G. L. and Stamatoyannopoulos, J. A. (2011) Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet., 43, 264-268.
15. Lin, C. Y., Vega, V. B., Thomsen, J. S., Zhang, T., Kong, S. L., Xie, M., Chiu, K. P., Lipovich, L., Barnett, D. H., Stossi, F. et al. (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet., 3, e87.
16. Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M. et al. (2009) Androgen receptor regulates a distinct transcription program in androgenindependent prostate cancer. Cell, 138, 245-256.
17. Yu, J., Yu, J., Mani, R. S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M. et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell, 17, 443-454.
18. Cirillo, L. A., McPherson, C. E., Bossard, P., Stevens, K., Cherian, S., Shim, E. Y., Clark, K. L., Burley, S. K. and Zaret, K. S. (1998) Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J., 17, 244-254.
19. Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M. and Zaret, K. S. (2002) Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell, 9, 279-289.
20. Bernardo, G. M., Lozada, K. L., Miedler, J. D., Harburg, G., Hewitt, S. C., Mosley, J. D., Godwin, A. K., Korach, K. S., Visvader, J. E., Kaestner, K. H. et al. (2010) FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development, 137, 2045-2054.
21. Gao, N., Ishii, K., Mirosevich, J., Kuwajima, S., Oppenheimer, S. R., Roberts, R. L., Jiang, M., Yu, X., Shappell, S. B., Caprioli, R. M. et al. (2005) Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development, 132, 3431-3443.
22. Mirosevich, J., Gao, N. and Matusik, R. J. (2005) Expression of Foxa transcription factors in the developing and adult murine prostate. Prostate, 62, 339-352.
23. Mirosevich, J., Gao, N., Gupta, A., Shappell, S. B., Jove, R. and Matusik, R. J. (2006) Expression and role of Foxa proteins in prostate cancer. Prostate, 66, 1013-1028.
24. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. and Carroll, J. S. (2011) FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet., 43, 27-33.
25. Lupien, M. and Brown, M. (2009) Cistromics of hormonedependent cancer. Endocr. Relat. Cancer, 16, 381-389.
26. Sahu, B., Laakso, M., Ovaska, K., Mirtti, T., Lundin, J., Rannikko, A., Sankila, A., Turunen, J. P., Lundin, M., Konsti, J. et al. (2011) Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J., 30, 3962-3976.
27. Wang, D., Garcia-Bassets, I., Benner, C., Li, W., Su, X., Zhou, Y., Qiu, J., Liu, W., Kaikkonen, M. U., Ohgi, K. A. et al. (2011) Reprogramming transcription by distinct classes of enhancers functionally defined by eRN A. Nature, 474, 390-394.
28. Gualdi, R., Bossard, P., Zheng, M., Hamada, Y., Coleman, J. R. and Zaret, K. S. (1996) Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev., 10, 1670-1682.
29. Bossard, P. and Zaret, K. S. (1998) GATA transcription factors as potentiators of gut endoderm differentiation. Development, 125, 4909-4917.
30. Asselin-Labat, M. L., Sutherland, K. D., Barker, H., Thomas, R., Shackleton, M., Forrest, N. C., Hartley, L., Robb, L., Grosveld, F. G., van der Wees, J. et al. (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol., 9, 201-209.
31. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A. et al. (2000) Molecular portraits of human breast tumours. Nature, 406, 747-752.
32. Yamaguchi, N., Ito, E., Azuma, S., Honma, R., Yanagisawa, Y., Nishikawa, A., Kawamura, M., Imai, J., Tatsuta, K., Inoue, J. et al. (2008) FoxA1 as a lineage-specific oncogene in luminal type breast cancer. Biochem. Biophys. Res. Commun., 365, 711-717.
33. Kouros-Mehr, H., Slorach, E. M., Sternlicht, M. D. and Werb, Z. (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell, 127, 1041-1055.
34. Eeckhoute, J., Keeton, E. K., Lupien, M., Krum, S. A., Carroll, J. S. and Brown, M. (2007) Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res., 67, 6477-6483.
35. Bohm, M., Locke, W. J., Sutherland, R. L., Kench, J. G. and Henshall, S. M. (2009) A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene, 28, 3847-3856.
36. Zhang, C., Wang, L., Wu, D., Chen, H., Chen, Z., Thomas-Ahner, J. M., Zynger, D. L., Eeckhoute, J., Yu, J., Luo, J. et al. (2011) Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer. Cancer Res., 71, 6738-6748.
37. Chen, Z., Zhang, C., Wu, D., Chen, H., Rorick, A., Zhang, X. and Wang, Q. (2011) Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J., 30, 2405-2419.
38. Langmead, B., Trapnell, C., Pop, M. and Salzberg, S. L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, R25.
39. Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W. et al. (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol., 9, R137.
40. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H. and Glass, C. K. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell, 38, 576-589.
41. Giresi, P. G., Kim, J., McDaniell, R. M., Iyer, V. R. and Lieb, J. D. (2007) FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res., 17, 877-885.
42. Zeng, R., Liu, Z., Sun, Y. and Xu, C. (2012) Differential expression and function of AR isoforms in prostate cancer. Oncol. Rep., 27, 492-498.
43. Cai, C., He, H. H., Chen, S., Coleman, I., Wang, H., Fang, Z., Chen, S., Nelson, P. S., Liu, X. S., Brown, M. et al. (2011) Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell, 20, 457-471.
44. Shah, S., Prasad, S. and Knudsen, K. E. (2012) Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. Cancer Res., 72, 1248-1259.
45. Ho, L. L., Kench, J. G., Handelsman, D. J., Scheffer, G. L., Stricker, P. D., Grygiel, J. G., Sutherland, R. L., Henshall, S. M., Allen, J. D. and Horvath, L. G. (2008) Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. Prostate, 68, 1421-1429.
46. Cai, C., Omwancha, J., Hsieh, C. L. and Shemshedini, L. (2007) Androgen induces expression of the multidrug resistance protein gene MRP4 in prostate cancer cells. Prostate Cancer Prostatic Dis., 10, 39-45.
47. Montani, M., Hermanns, T., Muntener, M., Wild, P., Sulser, T. and Kristiansen, G. (2013) Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Arch., 462, 437-443.
48. Massie, C. E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N. et al. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J., 30, 2719-2733.
49. Richter, S., Morrison, S., Connor, T., Su, J., Print, C. G., Ronimus, R. S., McGee, S. L. and Wilson, W. R. (2013) Zinc finger nuclease mediated knockout of ADP-dependent glucokinase in cancer cell lines: effects on cell survival and mitochondrial oxidative metabolism. PLoS One, 8, e65267.
50. Kaminski, M. M., Sauer, S. W., Kaminski, M., Opp, S., Ruppert, T., Grigaravicius, P., Grudnik, P., Grone, H. J., Krammer, P. H. and Gulow, K. (2012) T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. Cell Rep., 2, 1300-1315.
51. Nadiminty, N., Tummala, R., Liu, C., Yang, J., Lou, W., Evans, C. P. and Gao, A. C. (2013) NF-kappaB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants. Mol. Cancer Ther., 12, 1629-1637.
52. Perlmann, T. and Wrange, O. (1988) Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J., 7, 3073-3079.
53. Voss, T. C., Schiltz, R. L., Sung, M. H., Yen, P. M., Stamatoyannopoulos, J. A., Biddie, S. C., Johnson, T. A., Miranda, T. B., John, S. and Hager, G. L. (2011) Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell, 146, 544-554.
54. Calo, E. and Wysocka, J. (2013) Modification of enhancer chromatin: what, how, and why? Mol. Cell, 49, 825-837.
55. Seo, W. Y., Jeong, B. C., Yu, E. J., Kim, H. J., Kim, S. H., Lim, J. E., Kwon, G. Y., Lee, H. M. and Kim, J. H. (2013) CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2. Nucleic Acids Res., 41, 8526-8536.
56. Jin, Q., Yu, L. R., Wang, L., Zhang, Z., Kasper, L. H., Lee, J. E., Wang, C., Brindle, P. K., Dent, S. Y. and Ge, K. (2011) Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J., 30, 249-262.
57. Wu, D., Zhang, C., Shen, Y., Nephew, K. P. and Wang, Q. (2011) Androgen receptor-driven chromatin looping in prostate cancer. Trends Endocrinol. Metabol., 22, 474-480.
58. Wang, Q., Carroll, J. S. and Brown, M. (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell, 19, 631-642.
59. Hagege, H., Klous, P., Braem, C., Splinter, E., Dekker, J., Cathala, G., de Laat, W. and Forne, T. (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat. Protoc., 2, 1722-1733.
60. Hayakawa, F., Towatari, M., Ozawa, Y., Tomita, A., Privalsky, M. L. and Saito, H. (2004) Functional regulation of GATA-2 by acetylation. J. Leukoc. Biol., 75, 529-540.
61. Vakoc, C. R., Letting, D. L., Gheldof, N., Sawado, T., Bender, M. A., Groudine, M., Weiss, M. J., Dekker, J. and Blobel, G. A. (2005) Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1. Mol. Cell, 17, 453-462.
62. Fullwood, M. J., Liu, M. H., Pan, Y. F., Liu, J., Xu, H., Mohamed, Y. B., Orlov, Y. L., Velkov, S., Ho, A., Mei, P. H. et al. (2009) An oestrogen-receptor-alpha-bound human chromatin interactome. Nature, 462, 58-64.
63. Hu, Q., Kwon, Y. S., Nunez, E., Cardamone, M. D., Hutt, K. R., Ohgi, K. A., Garcia-Bassets, I., Rose, D. W., Glass, C. K., Rosenfeld, M. G. et al. (2008) Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl Acad. Sci. USA, 105, 19199-19204.
64. Kagey, M. H., Newman, J. J., Bilodeau, S., Zhan, Y., Orlando, D. A., van Berkum, N. L., Ebmeier, C. C., Goossens, J., Rahl, P. B., Levine, S. S. et al. (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature, 467, 430-435.
65. Andreu-Vieyra, C., Lai, J., Berman, B. P., Frenkel, B., Jia, L., Jones, P. A. and Coetzee, G. A. (2011) Dynamic nucleosomedepleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol. Cell. Biol., 31, 4648-4662.
66. Theodorou, V., Stark, R., Menon, S. and Carroll, J. S. (2013) GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res., 23, 12-22.